RaySearch Laboratories AB (publ) (FRA:27R)

RaySearch Laboratories AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	402.81	462.74	343.68	160.27	102.54	168.75
Cash & Short-Term Investments	402.81	462.74	343.68	160.27	102.54	168.75
Cash Growth	-7.44%	34.64%	114.44%	56.31%	-39.24%	48.21%
Accounts Receivable	451.45	444.78	383.73	370.57	317.36	300.75
Other Receivables	46.75	23.35	30.07	27.7	40.81	60.86
Receivables	498.19	468.13	413.79	398.26	358.17	361.61
Inventory	35.86	10.62	9.32	14.09	29.99	9.11
Prepaid Expenses	-	17.19	12.36	37.47	20.13	25.08
Other Current Assets	-	26.07	23.29	17.83	5.55	12.62
Total Current Assets	936.86	984.75	802.45	627.92	516.37	577.16
Property, Plant & Equipment	478.17	526.66	590.42	649.07	666.54	186.77
Other Intangible Assets	560.48	548.17	530.46	518.66	523.11	486.82
Long-Term Accounts Receivable	-	20.95	22.2	54.33	10	26.93
Long-Term Deferred Tax Assets	6.11	3.86	5.73	25.6	28.53	7.23
Other Long-Term Assets	7.48	6.79	1.43	0.36	0.21	-
Total Assets	1,989	2,091	1,953	1,876	1,745	1,285
Accounts Payable	34.45	38.76	42.09	24.03	48.77	19.86
Accrued Expenses	-	57.45	41.72	50.71	44.9	52.73
Current Portion of Long-Term Debt	-	-	-	-	21.27	49.65
Current Portion of Leases	76.49	77.08	97.38	81.31	49.11	42.87
Current Income Taxes Payable	-	42.16	5.49	4.98	3.71	2.84
Current Unearned Revenue	436.24	454.21	461.14	460.71	341.01	248.69
Other Current Liabilities	120.17	34.16	27.24	15.36	7.98	11.36
Total Current Liabilities	667.35	703.82	675.05	637.1	516.75	428.02
Long-Term Leases	353.49	394.86	431.98	474.08	491.02	52.91
Long-Term Deferred Tax Liabilities	118.45	114.92	109.53	106.87	107.78	108.75
Other Long-Term Liabilities	0.88	0.88	0.88	0.74	0.88	0.88
Total Liabilities	1,140	1,214	1,217	1,219	1,116	590.55
Common Stock	17.14	17.14	17.14	17.14	17.14	17.14
Additional Paid-In Capital	-	1.98	1.98	1.98	1.98	1.98
Retained Earnings	-	856.93	721.98	640.41	616.63	684.91
Comprehensive Income & Other	831.79	0.66	-5.87	-2.37	-7.44	-9.68
Shareholders' Equity	848.93	876.71	735.23	657.16	628.31	694.35
Total Liabilities & Equity	1,989	2,091	1,953	1,876	1,745	1,285
Total Debt	429.98	471.93	529.36	555.39	561.4	145.43
Net Cash (Debt)	-27.17	-9.19	-185.68	-395.12	-458.86	23.32
Net Cash Per Share	-0.79	-0.27	-5.42	-11.53	-13.38	0.68
Filing Date Shares Outstanding	34.28	34.28	34.28	34.28	34.28	34.28
Total Common Shares Outstanding	34.28	34.28	34.28	34.28	34.28	34.28
Working Capital	269.52	280.93	127.4	-9.18	-0.39	149.15
Book Value Per Share	24.76	25.57	21.45	19.17	18.33	20.25
Tangible Book Value	288.45	328.54	204.78	138.49	105.2	207.53
Tangible Book Value Per Share	8.41	9.58	5.97	4.04	3.07	6.05
Machinery	-	284.68	262.43	243.37	224.37	187.89
Order Backlog	-	1,813	1,864	1,940	1,363	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.